Skip to main content

Table 2 Laboratory data in patients with Kawasaki disease

From: Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease

  Patient without CAL (n=238) Patient with CAL (n=127) p value
WBC × 10 3 /mm 3 13.07 ± 0.29 14.14 ± 0.48 p=0.183
Hemoglobin g/dl 11.26 ± 0.07 10.96 ± 0.12 p=0.029*
Platelets× 10 3 /mm 3 331.84 ± 7.29 343.88 ± 11.11 p=0.248
Monocyte(%) 6.24 ± 0.23 5.64 ± 0.24 p=0.359
Eosinophil(%) 3.17 ± 0.21 3.54 ± 0.34 p=0.631
Basophil(%) 0.72 ± 0.14 1.07 ± 0.20 p=0.061
AST U/L 67.95 ± 6.06 79.16 ± 10.23 p=0.40
ALT U/L 74.52 ± 7.06 92.93 ± 10.14 p=0.049*
CRP mg/L 79.31 ± 4.44 104.21 ± 7.29 p=0.006*
Albumin g/dL 3.80 ± 0.03 3.59 ± 0.06 p=0.005*
Sodium mEq/L 136.35 ± 0.27 135.27 ± 0.50 p=0.072
PLR 59.39 ± 4.61 47.37 ± 2.61 p=0.124
NLR 2.73 ± 0.15 3.95 ± 0.39 p=0.004*
Neutrophils× 103/mm3 7.79 ± 0.26 9.10 ± 0.40 p=0.019*
Lymphocytes× 10 3 /mm 3 3.79 ± 0.11 3.52 ± 0.18 p=0.069
  1. Data are expressed as mean ± standard errors. ALT Alanine aminotransferase, AST Aspartate aminotransferase, CAL Coronary artery lesions, CRP C-reactive protein, NLR Neutrophil/lymphocyte ratio, PLR Platelet/ lymphocyte ratio, WBC White blood cells; *p < 0.05.